Registration
HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for TAKEDA PHARMACEUTICAL COMPANY, LIMITED
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Least costly alternative
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J BELL New | — |
| ROBERT D. KYLE New | Prin Assoc Dir, OMB; Sp. Asst to Pres., (contd.) |
| KATHLEEN M MCAULIFFE New | Associate Counsel, Office of House Minority Leader (contd.) |
| GWEN E MELLOR New | Intern, Office of Senator Joseph Biden |
| BETH L. ROBERTS New | — |
| REID PF STUNTZ New | Stff Dir/Chf Coun, Min.Stff Dir, Chf Coun, EN&Comm |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY, LIMITED | Japan | Japan | 100.0% | $100,000 |
Affiliated organisations
| Organisation | Location |
|---|---|
| ABBOTT LABORATORIES | Abbott Park, IL, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.